2022年(nian)3月5日(ri)，中(zhong)國中(zhong)藥協(xie)會在《中(zhong)國中(zhong)西醫(yi)結合雜(za)志》官網平(ping)臺首發《中(zhong)成藥防治新型(xing)冠(guan)狀(zhuang)病毒肺炎專家共識》，抗病毒口服液(ye)、參附注射(she)液(ye)、參麥注射(she)液(ye)、生脈注射(she)液(ye)等(deng)多(duo)個中(zhong)成藥被納(na)入。

為了充(chong)分(fen)發揮中(zhong)(zhong)(zhong)醫(yi)(yi)(yi)(yi)藥(yao)(yao)在(zai)應對新冠(guan)肺(fei)(fei)炎(yan)疫(yi)情中(zhong)(zhong)(zhong)的(de)作(zuo)用，貫(guan)徹落(luo)實中(zhong)(zhong)(zhong)西(xi)醫(yi)(yi)(yi)(yi)結合(he)救治新冠(guan)肺(fei)(fei)炎(yan)的(de)重要舉措，中(zhong)(zhong)(zhong)國(guo)中(zhong)(zhong)(zhong)藥(yao)(yao)協會(hui)(hui)(hui)受中(zhong)(zhong)(zhong)國(guo)人(ren)口福利基(ji)金會(hui)(hui)(hui)委托，由中(zhong)(zhong)(zhong)國(guo)中(zhong)(zhong)(zhong)藥(yao)(yao)協會(hui)(hui)(hui)呼吸(xi)病藥(yao)(yao)物(wu)研(yan)究(jiu)專(zhuan)業委員(yuan)會(hui)(hui)(hui)承擔，聯合(he)世(shi)界中(zhong)(zhong)(zhong)醫(yi)(yi)(yi)(yi)藥(yao)(yao)學會(hui)(hui)(hui)聯合(he)會(hui)(hui)(hui)呼吸(xi)病專(zhuan)業委員(yuan)會(hui)(hui)(hui)、中(zhong)(zhong)(zhong)國(guo)醫(yi)(yi)(yi)(yi)藥(yao)(yao)教育(yu)協會(hui)(hui)(hui)慢性氣道疾病專(zhuan)業委員(yuan)會(hui)(hui)(hui)，參照國(guo)家衛健委和(he)國(guo)家中(zhong)(zhong)(zhong)醫(yi)(yi)(yi)(yi)藥(yao)(yao)管理局印(yin)發《新型(xing)冠(guan)狀(zhuang)病毒(du)肺(fei)(fei)炎(yan)診(zhen)療方案（第(di)七版(ban)）》及《新型(xing)冠(guan)狀(zhuang)病毒(du)肺(fei)(fei)炎(yan)診(zhen)療方案（第(di)八版(ban)）》，梳理總結抗(kang)疫(yi)臨床(chuang)醫(yi)(yi)(yi)(yi)師和(he)患者用藥(yao)(yao)經驗，結合(he)部分(fen)中(zhong)(zhong)(zhong)成藥(yao)(yao)臨床(chuang)研(yan)究(jiu)成果(guo)和(he)國(guo)家藥(yao)(yao)品(pin)監督管理局對治療COVID-19中(zhong)(zhong)(zhong)成藥(yao)(yao)的(de)特別審批，制定該《專(zhuan)家共識》。

目前(qian)，華潤三九生(sheng)產的999抗病毒口服液(ye)、999參(can)附注射液(ye)、999參(can)麥注射液(ye)、999生(sheng)脈注射液(ye)等多個中成藥，將(jiang)充分發揮中醫藥的獨(du)特優勢，為全國(guo)打贏這場新冠阻擊“戰(zhan)疫”做出貢(gong)獻。